A critical discovery in cancer investigation is emerging with the use of VHH fragments to re-engage damaged p53. This essential malignant inhibitor protein is frequently disabled in various types of tumors, resulting https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research